This funding supports P50 SPORE grants for investigator-initiated translational research focused on improving prevention, early detection, diagnosis, and treatment of organ-specific or biologically related human cancers. Projects must involve human biology research and aim for translational endpoints within the grant period. Clinical trials are required. Eligible applicants include a broad range of U.S. institutions and organizations.
Eligible applicants include a wide range of U.S. entities such as county and state governments, institutions of higher education, nonprofits, for-profits, tribal governments, and small businesses. Foreign institutions are not eligible to apply, but foreign components of U.S. organizations are allowe
